In addition, the FDA can enforce the requirement that companies base safety designations on publicly available data. Third, the FDA can enforce the requirement that safety assessments consider vital health information such as a substance’s dietary sources, potential cancer risks and the cumulative health effects of similar substances.

Finally, the FDA can make companies revise and resubmit their data for review when they submit “Generally Recognized as Safe” notices that fail to comply with the criteria.

This is an excerpt. Read the original post here